• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ARCHITECT HAVAB-G; IGG ANTI-HAV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ARCHITECT HAVAB-G; IGG ANTI-HAV Back to Search Results
Catalog Number 06C29-22
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/13/2019
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product, architect havab-igg, list 6c29, that has a similar product distributed in the us, havab-g, list number 6c27.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Patient information: no further patient information was provided.Patient identifier: multiple = (b)(6).
 
Event Description
The customer reported multiple (b)(6) architect havab-igg results.The following results were provided: on (b)(6) 2019, (b)(6).No further information was provided and no impact to patient management was reported.
 
Manufacturer Narrative
A review of the complaint records for lot numbers 94521li00 and 95381li00 did not identify any problems related to false reactive results.Tracking and trending report review for the architect havab igg assay determined that there are no related adverse or non-statistical trends.Using worldwide field data the performance of reagent lots 94521li00 and 95381li00.The median and standard deviation to cutoff values of the negative population were within the established limits of the architect havab igg assay.Therefore, no unusual reagent performance was identified.Manufacturing documentation for the likely cause lot did not identify any issues associated with the complaint issue.Additionally, labeling was reviewed and sufficiently addresses the customer's issue.No systemic issue or deficiency of the architect havab igg assay was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HAVAB-G
Type of Device
IGG ANTI-HAV
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key8396124
MDR Text Key138148878
Report Number3002809144-2019-00088
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 05/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/06/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/22/2019
Device Catalogue Number06C29-22
Device Lot Number95381LI00
Was Device Available for Evaluation? Yes
Date Manufacturer Received05/07/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR, LIST 03M74-02.; ARCHITECT I2000SR, LIST 03M74-02.; SERIAL (B)(4).; SERIAL (B)(4).
-
-